statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

DUBLIN, Ireland, April 01, 2024 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that...

Avadel Pharmaceuticals to Present at the 23rd Annual Needham Healthcare Conference

Avadel Pharmaceuticals plc (NASDAQ:AVDL - Get Free Report) has received an average recommendation of "Buy" from the seven analysts that are presently covering the firm, MarketBeat reports. Seven...

Avadel Pharmaceuticals plc (NASDAQ:AVDL) Receives $22.57 Average Price Target from Analysts

This is a signal that AVDL's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...

Avadel Pharmaceuticals (AVDL, $16.59) RSI Indicator left the overbought zone on March 25, 2024

Shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL  Get Free Report) reached a new 52-week high on Friday . The stock traded as high as $17.43 and last traded at $17.37, with a volume of 177456...

Avadel Pharmaceuticals (NASDAQ:AVDL) Sets New 52-Week High at $17.43

This is a signal that AVDL's price trend could be reversing, and it may be an opportunity to sell the stock or take a defensive position...

Avadel Pharmaceuticals (AVDL, $17.22) Stochastic Oscillator left the overbought zone on March 22, 2024

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Avadel Pharmaceuticals call volume above normal and directionally bullish

This price move could be a signal that AVDL may fall back below the higher band and head toward the middle band. Traders may consider selling the stock, shorting the stock, or exploring put options...

Avadel Pharmaceuticals (AVDL, $17.09) price may drop as it broke higher Bollinger Band on Mar 21, 2024

Avadel Pharmaceuticals (AVDL, $17.09) RSI Indicator left the overbought zone on March 21, 2024

This indicator may be signaling AVDL's price has momentum to move higher, since its current price moved above its price 14 days ago. Traders may consider buying the stock or exploring call options...

Avadel Pharmaceuticals plc (AVDL, $16.57) entered Uptrend as Momentum indicator ascends above 0 level on Mar 20, 2024

This indicator may be signaling that AVDL's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...

Avadel Pharmaceuticals plc (AVDL, $15.78) entered Downtrend as Momentum indicator drops below 0 level on Mar 18, 2024

Avadel Pharmaceuticals Plc engages in the development and commercialization of pharmaceutical products. Its main product is LUMRYZ is an extended-release formulation of sodium oxybate, which used in the treatment of cataplexy or EDS in adults with narcolepsy. The company was founded on July 21, 1990 and is headquartered in Dublin, Ireland.

Volume	452,421.00
52-Wk High	$18.85
52-Wk Low	$9.50

AVDL Avadel Pharm Sp ADR

About

Feed

News

Sentiment

Earnings

Fundamentals